Follow
Karuppusamy V Karthik/Karthik V karuppusamy
Karuppusamy V Karthik/Karthik V karuppusamy
DST-INSPIRE Fellow
Verified email at nrcbsmku.org
Title
Cited by
Cited by
Year
Egr-1 mediated cardiac miR-99 family expression diverges physiological hypertrophy from pathological hypertrophy
S Ramasamy, G Velmurugan, B Rekha, S Anusha, KS Rajan, ...
Experimental cell research 365 (1), 46-56, 2018
252018
Chronic intake of 4-Methylimidazole induces Hyperinsulinemia and Hypoglycaemia via Pancreatic Beta Cell Hyperplasia and Glucose Dyshomeostasis
B Rekha, G Velmurugan, AJ Freddy, S Anusha, T Ramprasath, KV Karthik, ...
Scientific reports 8 (1), 17037, 2018
132018
The CCR5 Gene Edited CD34+CD90+ Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy
KV Karuppusamy, JP Demosthenes, V Venkatesan, AC Christopher, ...
Frontiers in Immunology 13, 792684, 2022
102022
The strategies and challenges of CCR5 gene editing in hematopoietic stem and progenitor cells for the treatment of HIV
KV Karuppusamy, P Babu, S Thangavel
Stem Cell Reviews and Reports, 1-12, 2021
92021
Preferential Expansion of Human CD34+CD133+CD90+ Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy
AC Christopher, V Venkatesan, KV Karuppusamy, S Srinivasan, P Babu, ...
Human Gene Therapy 33 (3-4), 188-201, 2022
72022
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
V Venkatesan, AC Christopher, M Rhiel, MKK Azhagiri, P Babu, ...
Molecular Therapy-Nucleic Acids 32, 671-688, 2023
62023
SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants
G Mahalingam, HK Rachamalla, P Arjunan, KV Karuppusamy, ...
Molecular Therapy 32 (5), 1284-1297, 2024
22024
CRISPR/Cas9 gene editing of hematopoietic stem and progenitor cells for gene therapy applications
V Venkatesan, AC Christopher, KV Karuppusamy, P Babu, MKK Alagiri, ...
JoVE (Journal of Visualized Experiments), e64064, 2022
22022
Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
R Murugesan, KV Karuppusamy, S Marepally, S Thangavel
Frontiers in Genome Editing 5, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–9